Repeat isolated limb perfusion with TNFα and melphalan for recurrent limb melanoma after failure of previous perfusion
E.M. Noorda(The Netherlands Cancer Institute), B.B.R. Kroon, Albertus N. van Geel, Alexander M.M. Eggermont(University Medical Center Utrecht), Omgo E. Nieweg(The University of Sydney), B. C. Vrouenraets(The Netherlands Cancer Institute)
Cited by 46
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k